ADHD medicine consumption in Europe after COVID-19: catch-up or trend change?
Abstract Background Although the COVID-19 pandemic and its implications have been associated with mental health services utilization and medication consumption, there is no longitudinal study on the long-term impact on ADHD medication use trends. Methods This study examines the European ADHD medicat...
Main Authors: | Sophie Gimbach, Daniel Vogel, Roland Fried, Stephen V. Faraone, Tobias Banaschewski, Jan Buitelaar, Manfred Döpfner, Richard Ammer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12888-024-05505-9 |
Similar Items
-
First-Time Users of ADHD Medication Among Children and Adolescents in Germany: An Evaluation of Adherence to Prescribing Guidelines Based on Claims Data
by: Oliver Scholle, et al.
Published: (2021-04-01) -
The impact of study design and diagnostic approach in a large multi-centre ADHD study. Part 1: ADHD symptom patterns
by: Roeyers Herbert, et al.
Published: (2011-04-01) -
Structural brain morphometry as classifier and predictor of ADHD and reward-related comorbidities
by: Daan van Rooij, et al.
Published: (2022-09-01) -
ADHD in adults in a nutshell
by: Ewa Rzeska, et al.
Published: (2024-01-01) -
Impact of ADHD as a Risk and a Treatment Factor in Intimate Partner Violence
by: N. Buitelaar
Published: (2022-06-01)